What a U.S. Study Found About the Shingles Vaccine and Dementia
Older U.S. adults who received the recombinant shingles vaccine had a lower incidence rate of dementia than their peers. Receiving the recombinant zoster vaccine also was linked to reduced risks of Alzheimer’s disease and vascular dementia. The analysis assessed dementia risk with the current two-dose shingles shot in the U.S., unlike other research. Older adults…
